Physician's First Watch Archive

Medical news from NEJM Journal Watch

March 31, 2017

By Amy Orciari Herman

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

When it comes to managing type 1 diabetes, patient education and training in insulin delivery — rather than choosing between an insulin pump and injections …

By the Editors

Here's today's offering from NEJM Group:

NEJM Knowledge+ Blog: To create the questions for NEJM Knowledge+ Pediatrics Board Review, the Knowledge+ team recruited authors from …

By Kelly Young

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

The World Health Organization aims to halve global medication errors — which …

By Cara Adler

Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS

Only one in three adults are asked about binge drinking at checkups, according to an MMWR article, …

March 30, 2017

By the Editors

Exposure to the quadrivalent human papillomavirus vaccine during pregnancy is not associated with adverse pregnancy outcomes, according to a New …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

New findings add to growing concerns surrounding increased rates of device thrombosis in patients who receive bioresorbable vascular scaffolds during percutaneous coronary …

By Kelly Young

Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM

The FDA has approved the injectable monoclonal antibody ocrelizumab (Ocrevus) to treat primary progressive multiple sclerosis (PPMS) and relapsing MS in adults. The treatment depletes B cells via binding by CD20.

In …

March 29, 2017

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Total knee replacement for knee osteoarthritis should be reserved for patients with more severe OA symptoms, according to …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

The FDA has approved dupilumab (Dupixent) to treat moderate-to-severe atopic dermatitis. It is indicated …

By Kristin J. Kelley

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

The FDA has approved niraparib …

By Joe Elia

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

The American Society of Clinical Oncology and Cancer Care Ontario have issued a joint updated guideline on …

By the Editors

The U.S. Preventive Services Task Force has concluded that the available evidence is insufficient to recommend for or against screening for celiac disease in asymptomatic …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM

Supplementation with vitamin D and calcium doesn't help prevent cancer in healthy older women, a JAMA study finds.

Some 2300 healthy women aged 55 …

By the Editors

Greater childhood lead exposure is tied to slightly lower cognitive function and socioeconomic status in adulthood, according to a JAMA study. …

March 28, 2017

By Amy Orciari Herman

Edited by Jaye Elizabeth Hefner, MD

An innovative strategy for diabetic retinopathy screening in primary care could significantly increase screening rates, cut screening wait times, and reduce unnecessary referrals to specialty care, a JAMA Internal …

By Kelly Young

Edited by Jaye Elizabeth Hefner, MD

Antibiotics may be effective for pediatric appendicitis, but they have a higher failure rate than appendectomy, particularly in the presence of appendicolith, according to a meta-analysis in JAMA Pediatrics …

March 27, 2017

By Kelly Young

Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH

Avoiding all tree nuts might not be necessary in people who have a single tree nut allergy, suggests a study in Annals of Allergy, Asthma and Immunology.

Researchers analyzed data from over 150 tree nut oral food …

Pages